ACM
BMY icon

Accent Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Accent Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-129
Closed -$6.96K – 342
2025
Q4 		$6.96K Hold
129
– – ﹤0.01% 251
2025
Q3 		$5.82K Sell
129
-541
-81% -$25.3K ﹤0.01% 294
2025
Q2 		$31K Buy
670
+129
+24% +$6.33K 0.01% 124
2025
Q1 		$33K Buy
+541
New +$31.5K 0.02% 120
2024
Q3 		– Sell
-900
Closed -$37.4K – 211
2024
Q2 		$37.4K Hold
900
– – 0.02% 103
2024
Q1 		$48.8K Hold
900
– – 0.04% 78
2023
Q4 		$46.2K Buy
+900
New +$47.2K 0.04% 97

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Accent Capital Management's BMY Position: Q1 2026 in Review

Accent Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 129 shares — an estimated $6.96K sold.

Accent Capital Management first reported a position in BMY in Q4 2023 and held it in 7 quarters. The position peaked at $48.8K in Q1 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Accent Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Accent Capital Management sold 129 Bristol-Myers Squibb shares in Q1 2026, an estimated $6.96K.
  • Accent Capital Management first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 7 quarters.
  • Accent Capital Management's Bristol-Myers Squibb position peaked at $48.8K in Q1 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Accent Capital Management's 13F filing for Q1 2026, filed 11 May 2026.